With the recent selection of CSC, Microsoft, and HealthUnity by the MetroChicago Health Information Exchange, I’m once again intrigued with the role that Microsoft might play in the HIT market. I suspect the MetroChicago project is more interested in HealthVault, but Amalga is the most interesting product in Microsoft’s struggling healthcare vertical. Amalga is a […]
PODCAST: One-on-One w/Microsoft Health Solutions Corporate VP Peter Neupert
Microsoft’s movement into healthcare has been slow, deliberate and fascinating. With products that now range from a PHR platform (HealthVault) to single-sign-functionality (Sentillion) to an information aggregation and analysis system (Amalga), the company is strategically picking up pieces of the healthcare continuum. But while Microsoft offers an HIS outside the United States, it says there […]
FDA Expands Gene Testing for Drug Prescription
“The FDA considers both unwanted harmful effects and lack of efficacy to be adverse events. When considering candidates for pharmacogenomic relabeling, the FDA evaluates the severity of the adverse reaction, the degree to which genetics predicts the reaction, and the total number of individuals likely to be affected. These factors are important in assessing the […]
One-on-One w/MedStar Health’s Gerry Higgins – Part 2
Gerald Higgins, PhD., MBA, MS, is not your typical CIO — that’s because Higgins is a chief innovation officer. Getting paid not to carry out EMR implementations or persuade physicians to embrace CPOE, Higgins is remunerated to “see what’s happening one or two hills over the horizon.” With a dizzying array of jobs and accomplishments […]
One-on-One w/MedStar Health’s Gerry Higgins
Gerald Higgins, PhD., MBA, MS, is not your typical CIO — that’s because Higgins is a chief innovation officer. Getting paid not to carry out EMR implementations or persuade physicians to embrace CPOE, Higgins is remunerated to “see what’s happening one or two hills over the horizon.” With a dizzying array of jobs and accomplishments […]